Innovent Biologics, Inc. (OTCMKTS:IVBXF – Get Free Report)’s stock price dropped 0.2% on Tuesday . The stock traded as low as $6.25 and last traded at $6.25. Approximately 180,649 shares changed hands during trading, an increase of 73% from the average daily volume of 104,502 shares. The stock had previously closed at $6.27.
Innovent Biologics Price Performance
The firm has a 50-day moving average price of $5.45 and a 200-day moving average price of $5.06.
About Innovent Biologics
Innovent Biologics, Inc, a biopharmaceutical company, develops and commercializes monoclonal antibodies and other drug assets in the fields of oncology, ophthalmology, autoimmune, and cardiovascular and metabolic diseases in the People's Republic of China. It offers Tyvyt, a human anti-PD-1 monoclonal antibody; BYVASDA, a fully-human anti-VEGF monoclonal antibody; HALPRYZA, a recombinant chimeric murine/human anti-CD20 monoclonal antibody; SULINNO, a fully-human antiTNF-a monoclonal antibody; Pemazyre, a selective FGFR inhibitor; Olverembatinib, a novel BCR-ABL TK; Cyramza, a VEGF receptor 2 antagonist; and Retsevmo, a selective and potent RET kinase inhibitor.
Read More
- Five stocks we like better than Innovent Biologics
- Ride Out The Recession With These Dividend Kings
- NVIDIA’s AI Dominance: Why Analysts Predict Major Upside Ahead
- Quiet Period Expirations Explained
- These Stocks Are Using Buybacks to Unlock Big Gains for Investors
- What is Put Option Volume?
- This Is the Entry Into PepsiCo You’ve Been Waiting For
Receive News & Ratings for Innovent Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovent Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
